About NOVODX
NOVODX is a company based in Boca Raton (United States) founded in 2022. NOVODX has raised $1.2 million across 2 funding rounds. NOVODX offers products and services including GoldN Reader and Health Tests. NOVODX operates in a competitive market with competitors including Access Bio, SD Biosensor, Lumos Diagnostics, Fluxergy and Module Innovations, among others.
- Headquarter Boca Raton, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Novo Dx Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.2 M (USD)
in 2 rounds
-
Latest Funding Round
$200 K (USD), Seed
Mar 06, 2025
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NOVODX
NOVODX offers a comprehensive portfolio of products and services, including GoldN Reader and Health Tests.
Reusable tool for quick at-home tests of health indications.
Rapid testing kits for conditions like thyroid and COVID.
Funding Insights of NOVODX
NOVODX has successfully raised a total of $1.2M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $200 thousand completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by NOVODX
Investment portfolio details for NOVODX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NOVODX
Detailed financials for NOVODX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novodx Comparisons
Peer comparison for NOVODX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NOVODX
NOVODX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Access Bio, SD Biosensor, Lumos Diagnostics, Fluxergy and Module Innovations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases.
|
|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
Diversified diagnostic assays and readers are developed for point-of-care use.
|
|
| Locked | Locked | Locked |
Provides diagnostic devices and software for clinical and veterinary point-of-care testing.
|
|
| Locked | Locked | Locked |
Diagnostics strip for bacterial detection
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic products for diabetes and tuberculosis are provided.
|
Detailed competitors of NOVODX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novodx
Complete news archive for NOVODX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NOVODX
NOVODX was founded in 2022 and raised its 1st funding round 1 year after it was founded.
NOVODX is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
Nancy Torres Kaufman is the current CEO of NOVODX.
NOVODX is a funded company, having raised a total of $1.2M across 2 funding rounds to date.
NOVODX was founded in 2022 in Boca Raton, United States, within the diagnostics sector. Point-of-care tests are developed for over-the-counter self-testing at home and professional use in clinics. Reusable quantitative and qualitative meters are employed to replicate clinical laboratory results. Applications cover respiratory diseases, infectious conditions, and aspects of mens and womens health.
NOVODX's top competitors include Access Bio, SD Biosensor and Lumos Diagnostics.
NOVODX offers GoldN Reader and Health Tests.